These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3955843)

  • 1. The analysis of data from breast cancer estrogen and progesterone receptor assays: Scatchard plots are inferior to direct fitting by computer.
    Cooke RR; McIntosh JE
    Clin Chim Acta; 1986 Feb; 154(3):171-9. PubMed ID: 3955843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology.
    Giri DD; Goepel JR; Rogers K; Underwood JC
    J Clin Pathol; 1988 Apr; 41(4):444-7. PubMed ID: 3366932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptor assays in human breast cancer. A brief review of the relevant terms, methods, and clinical usefulness.
    Sundaram GS; Manimekalai S; Wenk RE; Goldstein PJ
    Obstet Gynecol Surv; 1984 Dec; 39(12):719-23. PubMed ID: 6514255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
    Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
    [No Abstract]   [Full Text] [Related]  

  • 5. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
    Helin H; Isola J; Helle M; Koivula T
    Br J Cancer; 1990 Jul; 62(1):109-12. PubMed ID: 2202418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.
    Fernö M; Borg A
    Anticancer Res; 1985; 5(3):307-12. PubMed ID: 4015045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer: estrogen and progesterone receptor assays as a guide to therapy.
    Jiang NS
    Mayo Clin Proc; 1983 Jan; 58(1):64. PubMed ID: 6823155
    [No Abstract]   [Full Text] [Related]  

  • 8. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
    Curtin CT; Pertschuk LP; Mitchell V
    Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of estrogen and progesterone receptors in small samples of breast cancer: I. Mathematical analysis of total binding data.
    Piantanelli L; Rossolini G; Viticchi C; Basso A
    Boll Soc Ital Biol Sper; 1994; 70(8-9):221-7. PubMed ID: 7893480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
    Luoh SW; Ramsey B; Park B; Keenan E
    Breast J; 2014; 20(1):46-52. PubMed ID: 24261828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation.
    Mohammed RH; Lakatua DJ; Haus E; Yasmineh WJ
    Cancer; 1986 Sep; 58(5):1076-81. PubMed ID: 3015374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysing data from hormone-receptor assays.
    Cressie NA; Keightley DD
    Biometrics; 1981 Jun; 37(2):235-49. PubMed ID: 7272412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
    Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
    Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on estradiol receptor assays in human breast cancer tissue.
    Mulder J; Verhaar MA
    Clin Chim Acta; 1979 Dec; 99(2):129-34. PubMed ID: 509736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?)].
    Kahán Z
    Orv Hetil; 1996 Oct; 137(42):2305-8. PubMed ID: 8992428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of estrogen and progesterone receptors in small samples of breast cancer: II. The conventional procedure compared to the mathematical one.
    Viticchi C; Basso A; Piantanelli L; Zaia A
    Boll Soc Ital Biol Sper; 1994; 70(8-9):229-34. PubMed ID: 7893481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are progesterone receptor assays needed in post-menopausal, estrogen receptor-negative patients?
    Brocklehurst D; Wilde CE; Edwards CE; Dewhurst DG
    Clin Chem; 1986 Nov; 32(11):2120. PubMed ID: 3779973
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.
    Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J
    Oncology; 1994; 51(5):435-9. PubMed ID: 8052485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardization of receptor diagnosis in breast cancer].
    Hickler W; Scheiermann N; Riffelmann HD; Kreuzfelder E
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1931-3. PubMed ID: 3780470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.